HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoCalendarPricing
Theme 		Help
Elite 50% OFF Act now – get top investing tools Register Now!
Market News Stocks News ETF News Crypto News

Apellis Pharmaceuticals, Inc.; Sobi

Contributing Author

Recent Articles by Apellis Pharmaceuticals, Inc.; Sobi

Jun-06
Apellis and Sobi Announce EMPAVELI (pegcetacoplan) Showed Sustained Efficacy at One Year in Phase 3 Study for C3G and Primary IC-MPGN APLS GlobeNewswire
Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2025 Finviz.com. All Rights Reserved.